Literature DB >> 92676

1,25-dihydroxyvitamin-D-receptor in breast cancer cells.

J A Eisman, T J Martin, I MacIntyre, J M Moseley.   

Abstract

A specific receptor for 1,25-dihydroxyvitamin D has been demonstrated in a cultured human breast cancer cell line. This is the first such demonstration in any cancer cell. It may explain the high incidence of metastatic bone destruction and hypercalcaemia in this common malignancy, and the limited success of other steroid-receptor assays in predicting the response of breast cancer to therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92676     DOI: 10.1016/s0140-6736(79)92816-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel David Bikle
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

Review 2.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

3.  Rapid and simultaneous detection of vitamin D receptor gene polymorphisms by a single ARMS-PCR assay.

Authors:  Mohammad Jafari; Aliyar Pirouzi; Saber Anoosheh; Parisa Farnia; Nader Tajik
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

4.  Effect of vitamin D receptor knockout on cornea epithelium wound healing and tight junctions.

Authors:  Rodolfo A Elizondo; Zhaohong Yin; Xiaowen Lu; Mitchell A Watsky
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

Review 5.  Minireview: Vitamin D: is there a role in extraskeletal health?

Authors:  Sylvia Christakos; Hector F DeLuca
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

6.  Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.

Authors:  Jamila Al-Azhri; Yali Zhang; Wiam Bshara; Gary Zirpoli; Susan E McCann; Thaer Khoury; Carl D Morrison; Stephen B Edge; Christine B Ambrosone; Song Yao
Journal:  Clin Cancer Res       Date:  2016-07-12       Impact factor: 12.531

Review 7.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

8.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

9.  Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Authors:  Nair Lopes; Bárbara Sousa; Diana Martins; Madalena Gomes; Daniella Vieira; Luiz A Veronese; Fernanda Milanezi; Joana Paredes; José L Costa; Fernando Schmitt
Journal:  BMC Cancer       Date:  2010-09-11       Impact factor: 4.430

10.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.

Authors:  U A Liberman; C Eil; S J Marx
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.